S&P 500 & Moderna
3 shared events · Importance 4 · Last updated Aug 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
S&P 500: The S&P 500 fell 0.87% to 7,641.16, ending about 2% below its record close. The index was pressured by rising yields, weak retail earnings, and oil-driven inflation worries.
Moderna: Moderna fell 23.5% after surging 177% the previous day, making it the biggest decliner in healthcare.
Aug 20, 2026 · 15 articles
Tech
S&P 500: The S&P 500 gained modestly, with healthcare stocks leading, partly due to the trial news.
Moderna: Moderna is the developer of the mRNA vaccine and the primary beneficiary, with its stock surging over 120% and market cap increasing by nearly $40 billion. The trial success validates its mRNA platform beyond COVID-19 and could lead to a new revenue stream.
Aug 19, 2026 · 102 articles
International
S&P 500: The S&P 500 is affected by oil prices and geopolitical uncertainty, but has been near record highs.
Moderna: Moderna is a pharma company, not directly affected.
Jun 16, 2026 · 349 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how S&P 500 and Moderna interact across events, view sentiment trends, and discover connected entities.
Open Dashboard